Japan Asia Investment

Provider of asset management services intended to offer financial products. The company assist in real estate investment management business centered on distribution warehouses and invests in real estate in Japan and overseas, enabling clients to avail asset management assistance.

Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, particularly through its innovative microwave mammography system. This technology effectively addresses the challenges associated with scattering microwaves in high-density breasts, producing clear images that assist healthcare professionals in accurately distinguishing between cancerous and normal tissue. By providing a more reliable imaging solution, Integral Geometry Science aims to reduce unnecessary pain and radiation exposure for patients compared to traditional screening methods. Additionally, the company manufactures a nondestructive inspection system specifically for lithium-ion batteries.

CROCO Corporation, established in 2015 and headquartered in Tokyo, Japan, provides a range of services including web marketing, crowd sourcing, and plagiarism checks. The company emphasizes its commitment to social responsibility, particularly in the protection of personal information it manages. Through its various offerings, CROCO aims to enhance online engagement and ensure content integrity while prioritizing the privacy and security of its users' data.

Last One Mile Co Ltd specializes in providing essential utility services and technology solutions for both business-to-business (B2B) and business-to-consumer (B2C) markets. The company offers a range of services, including new connections for electricity, gas, and internet, as well as IT services and infrastructure support such as Wi-Fi and Internet of Things (IoT) solutions. By focusing on these critical areas, Last One Mile aims to enhance connectivity and reliability for its customers, addressing their diverse energy and technology needs.

YAMAP is born to make your outdoors, such as hike or ski, more safety, and more enjoyable with your iPhone. YAMAP App can track and log your outdoors, view elevation info, and build an online outdoor journal. Love & share the outdoors with YAMAP ! ■■ Three Main Features of YAMAP ■■ 1) Safe ◆YAMAP App makes your iPhone a special GPS device for the outdoors. YAMAP App could provide accurate positioning information with YAMAP's maps in Japan and your iPhone's GPS, even if you are in places not reached by mobile phone signals, such as in mountainous regions. 2) Convenience ◆ YAMAP Hybrid Maps YAMAP's maps are used as digital ones with your iPhone, and as ones on paper by downloading them to your PC (or tablet PC). 3) Share ◆You can easily share your outdoor data with your family and friends through YAMAP Web service. Once you finish your outdoor and save your data, YAMAP App automatically uploads to your online 'ACTIVITY REPORT' on YAMAP Web service (http://yamap.co.jp) where you can view your route, outdoor data, and a comprehensive workout history. In addition, YAMAP gives you the ability to easily share your outdoor data with friends and family.

Megakaryon Corporation develops platelets and red blood cells from human iPS cell lines. Its portfolio includes blood products that do not depend on blood donations. The company was founded in 2011 and is based in Kyoto, Japan with an additional office in Tokyo, Japan.

Nippon Souken Ltd., founded in 1996 and based in Takamatsu, Japan, specializes in insurance brokerage services and risk management support. The company focuses on analyzing various risks to provide comprehensive solutions for its clients. By leveraging its expertise in risk assessment, Nippon Souken aims to enhance the safety and security of businesses in an ever-evolving risk landscape.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

FacePeer, Inc., founded in 2015 and based in Tokyo, Japan, develops a web-based communications platform known as FaceHub. The company specializes in a video call platform tailored for conducting recruitment interviews, facilitating effective online communication between businesses and customers. By focusing on business-to-business-to-customer interactions, FacePeer aims to enhance the efficiency of online job interviews, thereby supporting the sustainable growth of companies.

Developer of an online platform intended for designer handbags. The company's online fashion-sharing platform allows its users to borrow high-end designer handbags for unlimited time with free replacements, enabling women to get fashion items as per their preferences in their budget.

J-ARM Co.Ltd. is engage in cell therapy; introduction and support of regenerative medicine; and research and development of cell culture. The company is based in Osaka, Japan.

Wonderplanet Inc. designs and develops native language applications and games for smart phones and tablets. It provides 2D and 3D games for iOS and android. The company was founded in 2012 and is based in Nagoya, Japan.

Ligua Inc. is a consultancy firm based in Osaka, Japan, specializing in management support services for the healthcare sector. Established in 2004, the company provides a range of consulting services that include enhancing sales office operations, organizational management, executive education, and recruitment. Additionally, Ligua focuses on corporate management by assisting in the management of key performance indicators and the development of business plans. The firm also offers problem-solving tools tailored for osteopaths, as well as services related to insurance agency and financial product brokerage, along with medical expenses billing. Through its comprehensive offerings, Ligua aims to create positive outcomes in both health and finance.

TORICO Co., Ltd. is an online platform based in Tokyo, Japan, specializing in the sale of books, including e-books and manga. Founded in 2005, the company operates the Comic EC MANGAZENKAN.COM, which focuses on manga and Japanese animation goods. In addition to its retail offerings, TORICO is involved in the planning, development, marketing, and sales of various manga-based services, catering to a diverse audience of manga enthusiasts.

Wonderleague, founded in June 2014, operates in the game-related business, focusing on the development and manufacturing of virtual reality (VR) and augmented reality (AR) products. The company produces VR and AR goggles and controllers designed to deliver high-quality interactive experiences across iOS and Android devices. In addition to hardware, Wonderleague is actively developing an AR platform that enhances user engagement. The company also aims to advance the e-sports industry by providing an open-source electronic sports platform that promotes sports education and facilitates competitive gaming through various tournaments.

FacePeer, Inc., founded in 2015 and based in Tokyo, Japan, develops a web-based communications platform known as FaceHub. The company specializes in a video call platform tailored for conducting recruitment interviews, facilitating effective online communication between businesses and customers. By focusing on business-to-business-to-customer interactions, FacePeer aims to enhance the efficiency of online job interviews, thereby supporting the sustainable growth of companies.

FunPep Company Limited is a biotechnology firm based in Tokyo, Japan, specializing in the research and development of pharmaceuticals, cosmetics, and medical devices utilizing functional peptides. Founded in 2013, the company is currently advancing several peptide-based treatments, including SR-0379, aimed at addressing intractable skin ulcers, and FPP003, which is undergoing Phase I/IIa clinical trials for psoriasis in Australia, alongside preclinical studies for ankylosing spondylitis in Japan. Additionally, FunPep is developing FPP004, an antibody-inducing peptide targeted at pollinosis. The company's innovative approach emphasizes the therapeutic potential of peptides across various health-related applications.

Aoi Co. is a Tokyo-based company that provides "Aoi Zemi," a free online lecture service designed for junior high and middle school students. The platform has successfully attracted over 3,000 users and boasts an impressive entrance exam passing rate of 86.3% for students aiming for their preferred universities. Aoi Co. is focused on enhancing its system development capabilities and plans to launch a learning state monitoring app for parents in September.

Eltes Co Ltd provides consultation services based on digital risk technology for database risk and other large storage protection in Japan. It also offers internal fraud detection services that enable the prevention of information security breaches caused by internal factors; and a service that includes detection and diagnosis of security breaches caused by external factors.

FunPep Company Limited is a biotechnology firm based in Tokyo, Japan, specializing in the research and development of pharmaceuticals, cosmetics, and medical devices utilizing functional peptides. Founded in 2013, the company is currently advancing several peptide-based treatments, including SR-0379, aimed at addressing intractable skin ulcers, and FPP003, which is undergoing Phase I/IIa clinical trials for psoriasis in Australia, alongside preclinical studies for ankylosing spondylitis in Japan. Additionally, FunPep is developing FPP004, an antibody-inducing peptide targeted at pollinosis. The company's innovative approach emphasizes the therapeutic potential of peptides across various health-related applications.

TMS Co., Ltd. is a Tokyo-based clinical-stage biotechnology company specializing in the development of drug candidates and medical technologies derived from academic research. Founded in 2005, TMS focuses on fungus-derived small molecule compounds known as SMTPs, which exhibit dual modes of action, providing both thrombolytic and anti-inflammatory effects. The company's lead compound, TMS-007, is currently undergoing Phase IIa clinical trials for the treatment of acute ischemic stroke and is partnered with a prominent biotech firm. TMS aims to advance its innovative medical products to address significant health challenges.

Megakaryon Corporation develops platelets and red blood cells from human iPS cell lines. Its portfolio includes blood products that do not depend on blood donations. The company was founded in 2011 and is based in Kyoto, Japan with an additional office in Tokyo, Japan.

Access Bright Japan, Inc. publishes and operates smartphone games in China. The company provides services for social game developers and content providers to monetize in Chinese market. It also distributes Chinese films. Access Bright Japan, Inc. was founded in 2011 and is based in Minato, Japan with an additional office in Shanghai, China.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Access Bright Japan, Inc. publishes and operates smartphone games in China. The company provides services for social game developers and content providers to monetize in Chinese market. It also distributes Chinese films. Access Bright Japan, Inc. was founded in 2011 and is based in Minato, Japan with an additional office in Shanghai, China.

JMC Corporation, founded in 1992 and headquartered in Yokohama, Japan, specializes in manufacturing and selling 3D printers, sand mold casting products, and a variety of related parts. The company also provides 3D printing and sand casting services, along with inspection and measurement services utilizing computed tomography (CT) for industrial applications. Additionally, JMC offers training systems for cardiac catheterization.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

TMS Co., Ltd. is a Tokyo-based clinical-stage biotechnology company specializing in the development of drug candidates and medical technologies derived from academic research. Founded in 2005, TMS focuses on fungus-derived small molecule compounds known as SMTPs, which exhibit dual modes of action, providing both thrombolytic and anti-inflammatory effects. The company's lead compound, TMS-007, is currently undergoing Phase IIa clinical trials for the treatment of acute ischemic stroke and is partnered with a prominent biotech firm. TMS aims to advance its innovative medical products to address significant health challenges.

Rich Media offers media portal, Web creation, and search engine optimization (SEO) services.

BioAmber is a private US company registered in the state of Delaware. The company, formerly known as DNP Green Technology, changed its name to BioAmber following its acquisition of its joint venture with ARD. Following the transaction, they adopted the name BioAmber, which had been used to that point by the joint venture.

Purple Blue Bo is a digital marketing company provides internet marketing and search engine optimisation.

Analogix Semiconductor, Inc. specializes in designing and manufacturing high-performance analog and mixed-signal semiconductor devices tailored for the digital multimedia and communications sectors. The company offers a range of products, including SlimPort solutions, timing controllers, mobile display converters, accessory display converter chips, and display controllers, which facilitate the delivery of high-resolution video, audio, and data across various portable devices such as smartphones, tablets, and laptops. Notably, its SlimPort ANX7688 enables 4K video output, supporting advanced resolutions from mobile devices. Founded in 2002 and headquartered in Santa Clara, California, Analogix also maintains offices in Beijing, Shenzhen, Taiwan, South Korea, and Japan, positioning itself as a significant player in the digital media market, particularly in DisplayPort and HDMI technology solutions.

Chiral Quest specializes in the development and supply of intermediates essential for the production of innovative pharmaceuticals. With a team of experienced chemists, the company excels in transforming lab-scale processes into practical and scalable manufacturing methods. Their primary focus is on the development and manufacture of chiral catalysts, which play a crucial role in producing high-quality drug intermediates for the global generic drug industry. Through their expertise in process development, Chiral Quest aims to deliver cost-effective solutions while supporting the pharmaceutical sector in meeting its evolving needs.

Palo Alto Networks is a leading cybersecurity company that provides a comprehensive platform for protecting organizations from cyber threats. Headquartered in California, the firm offers a range of products focused on network security, cloud security, and security operations. With a customer base exceeding 80,000 enterprises, including a significant portion of the Global 2000, Palo Alto Networks employs innovative technologies to enable safe application usage and prevent security breaches. The company's advanced threat prevention capabilities are designed to deliver superior protection compared to traditional security solutions, thereby safeguarding valuable assets and supporting the daily operations of businesses worldwide. Additionally, Palo Alto Networks co-manages a venture capital fund that invests in the SaaS and cybersecurity sectors, further emphasizing its commitment to fostering innovation in the industry.

Sales Robotics Co., Ltd., founded in 2004 and based in Tokyo, Japan, specializes in developing and providing cloud-based business support services. The company focuses on building customer databases and sales pipelines, as well as offering sales strategy consulting and inside sales support. Its platform includes services for language education, marketing, and sales, alongside system development and IT solutions. By enabling businesses to analyze data effectively, Sales Robotics assists in preparing optimized sales strategies and constructing comprehensive support systems for various operational needs.

GZ.com, Inc. is a provider of online solutions based in Guangzhou, China, specializing in a range of digital services. The company operates several platforms, including DNParking.com, which focuses on parking solutions; Yejie.com, a comprehensive domain marketplace for investors; and Hangye.com, a direct navigation site offering industry-specific information services. Additionally, GZ.com runs Xingkong.com, an online wish site featuring localized functionalities, and 114China.com, which provides yellow pages services. Through these platforms, GZ.com aims to deliver effective online branding, domain registration, and direct marketing services to support businesses in their digital endeavors.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Chestnut Medical Technologies, Inc. was founded to pioneer new minimally invasive therapies for Interventional Neuroradiology. Chestnut's mission is to develop technologies that are easier to use while improving outcomes and reducing complications in the treatment of neurovascular disease.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Ecrio provides optimized, standards compliant software clients and development resources to mobile phone service providers and device manufacturers for mobile commerce and real time communications. The Ecrio Mobile Communications Client Suite (MCCS) transforms everyday applications into communication-rich applications. The MCCS framework reduces the complexity and effort required to add rich communication functions to applications ranging from Voice and SMS to video telephony, content sharing, social communications and enterprise solutions. Applications running in common application environments, developed using standard SDK tools on a wide range of device types and platforms can be easily upgraded to communication-rich applications using the framework’s rich set of functions and its simple access methods. The Ecrio MCCS solves the challenges of enabling and sharing high-value and complex communication capabilities among multiple applications and devices, reducing the incremental effort, cost, and risk of deploying and using new LTE and IMS service capabilities. It accelerates application development resulting in more uses and optimized experiences expanding the individual value and market reach and achieving a higher value for the service capability investment.

Moshimo enables small businesses to easily sell merchandise online by offering an efficient way to build an online shop front. In addition, Moshimo provides drop shipping, a supply chain management technique where the wholesale supplier, not the small business, holds and ships the product. This system eliminates the difficulties of designing an online store, holding inventory, and sending goods. Moshimo offers their users the opportunity to sell over 350,000 different products sourced from more than 800 wholesale suppliers.

A privately held technology company headquartered in London.

Tudou is a Chinese video sharing website that enables young users to get their voices heard on mainstream network media platforms. Launched on April 15, 2005, by its founder Wang Tei, Tudou was listed on NASDAQ on August 17 that same year. Tudou.com completed its fifth round of financing for $40 million dollars in 2010. In 2012, Tudou was acquired by Youku in a stock-for-stock transaction, and the merger of China's two biggest online video companies was finalized after shareholders approved the deal on August 20, 2012. The new entity was named Youku Tudou, Inc. According to iResearch, the number of monthly unique visitors to the site increased from approximately 182 million in December 2010 to about 227 million in May 2013, giving Youku Tudou, Inc. the advantage in terms of user base over its major rivals, Sohu, PPTV and iQiyi.

Net-Marketing Corporation operates as an advertisement agent in Japan. The company is based in Tokyo, Japan.

B.Creation offers digital services and development of smartphone application useful for fishing and outdoors. The company was established on March 29, 2004.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

BlogBus is a pioneering blog hosting service provider based in China, recognized as the first commercial entity to offer paid blogging services in the Chinese blogosphere. The company focuses on internet community services, catering to the growing demand for personal and professional blogging platforms. By establishing a reputation for quality and reliability, BlogBus has positioned itself as a key player in the Chinese blogging industry, facilitating users in creating and managing their online content effectively.

Broncus Medical develops innovative diagnostic and therapeutic navigation technologies aimed at treating lung diseases. The company offers a range of products, including the Archimedes System, which features bronchoscopic trans-parenchymal needle access for virtual bronchoscopic planning and navigation, and the Lungpoint Virtual Bronchoscopic Navigation system that enables real-time navigation within the lungs for biopsy procedures. Additionally, Broncus is advancing its Exhale product line, which includes the Airway Bypass procedure, a minimally-invasive treatment for homogeneous emphysema, a prevalent form of the disease. The company is currently conducting the pivotal EASE Trial to evaluate this treatment. Founded in 1997 and originally named Broncus Technologies, the company is headquartered in San Jose, California, with additional operations in Shanghai, China, and Mountain View, California. Broncus Medical focuses on addressing the unmet medical needs in interventional pulmonology, improving the diagnosis and treatment of lung cancer and chronic obstructive pulmonary disease (COPD).

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Tixa Internet Technology Co., Ltd., headquartered in Beijing, specializes in web-empowered products, systems, and services, primarily focusing on contextual advertising solutions for online advertisers and publishers in China. The company's offerings include NarrowAD, a targeted online ad solution, and ChinaWi, an online corporate intelligence portal. Additionally, Tixa operates PRnews, a platform that facilitates the distribution of press releases to various media outlets and decision-makers. The company also provides media monitoring services, press release writing and translation, and crisis management support. Tixa's multi-channel delivery network ensures real-time access to diverse audiences, including daily newspapers, trade publications, and individual consumers. Established in 2000 and formerly known as VeryE, Tixa underwent a rebranding in 2004 following investment from Mitsui Sumitomo Financial Group.

Azteq Mobile manufactures and markets mobile devices, palm tops, communication equipment, and handheld devices. The company is based in Walnut Creek, California.

SymBio Pharmaceuticals Limited is a biopharmaceutical company based in Tokyo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs, primarily in the fields of oncology and hematology. The company develops various anti-cancer agents, including Treakisym, which is used to treat non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia, and is currently undergoing Phase III trials for relapsed/refractory diffuse large B-cell lymphoma. Additionally, SymBio is working on several other drug formulations, including SyB L-1701, SyB L-1702, and Rigosertib SyB-C-0501, as well as SyB L-1101 and SyB C-1101 for higher-risk myelodysplastic syndromes. The company also has a candidate, SyB V-1901, aimed at treating infectious diseases. SymBio Pharmaceuticals operates primarily in Japan, South Korea, China, Hong Kong, Taiwan, and Singapore.

Crooz is a Japanese company that specializes in mobile games and e-commerce applications. As a prominent provider of mobile social games, it offers original titles on platforms such as Mobage and has seen significant revenue generation, with some games earning over US$1 million per month. In addition to its gaming division, Crooz operates several e-commerce platforms, including SHOPLIST.com, a site for purchasing fast fashion items, and SHOPLIST USED, which facilitates the buying and selling of used fashion goods. The company also runs SHOPZONE, another fast fashion mail-order site, and maintains a blogging platform known as CROOZblog. With a strategic focus on expanding its international presence, Crooz aims to leverage the growth of the global smartphone game industry while solidifying its position in the domestic market.

A storage company focused on holographic data storage technology.

SMS is mainly engaged in the information operation businesses in nursing care, healthcare, career, senior life and overseas fields to business operators and end user, among others.

Magink Display Technologies Ltd. is a company that specializes in digital display technologies, focusing on providing touch screen solutions primarily for the casino sector. Founded in 2000 and headquartered in Mevasseret Zion, Israel, with additional offices in the United Kingdom and San Francisco, the company’s products are utilized in gaming machines across the United States and Australia. Magink addresses the Out-of-Home media market, offering applications for outdoor advertising, retail signage, public information, and promotional displays. The company is dedicated to the ongoing development of its proprietary technology, which features full-color, high-resolution digital ink display systems known for their low energy consumption and cost-effectiveness. This technology is being tested and deployed in various global markets, enhancing digital display applications across diverse industries.

Beat Holdings Limited(Formerly known as Xinhua Finance Limited) is a multi-disciplinary group company doing businesses in China and the rest of Asia, including Japan. The company currently offers products and devices in the areas of financial services, public relations and developing and operating application software for smartphones, telecom software platforms, global messaging gateways and mobile advertising platforms. The Company offers products and services in the areas of financial services. Listed on TSE's Second Section (9399), Xinhua Holdings is headquartered in Hong Kong, with a global network spanning China and Japan. China's economic development has drastically improved the country's standard of living considerably and has set the stage for China to focus on sectors that are vital for future sustainable development. Combining their financial expertise in China and global network, they seek to introduce internationally-proven standards and essential products and services that facilitate business and investment in China. At Xinhua Holdings, they provide the tools and know-how upon which global and domestic organizations can execute high-value decisions with confidence, care, and clarity. Leveraging the value of their products and services, client base and brand names, they, aim to serve as a bridge between China's markets, business opportunities and the world and act as a business incubator in China.

istyle, Inc. engages in the management of beauty-related online platform as well as the provision of advertising, marketing, and research services. It operates through the following segments: On Platform, Beauty Service, Global, and Others. The On Platform segment deals with domestic and overseas marketing, as well as premium membership services. The Beauty Service segment manages domestic cosmetics electronic commerce sites in addition to its specialty shop @cosme store. The Global segment includes services developed overseas. The Others segment covers beauty staff dispatching and investment training services. It has overseas subsidiaries including in Taiwan, China, Hong Kong, Malaysia, Singapore, Thailand and The United States.

Triage Medical Inc., an Irvine, Calif.-based developer orthopedic trauma devices.

Rinat Neuroscience, founded in 2001 following a spin-out from Genentech, focuses on developing protein-based therapeutics for various neurological diseases and disorders. The company leverages significant research and development resources previously invested by Genentech to advance its pioneering efforts in antibody drug development. Rinat is dedicated to creating innovative treatments for conditions such as pain, Alzheimer's disease, obesity, diabetes, and neuropathies. Additionally, it is engaged in developing novel therapies aimed at modifying disease progression by targeting and protecting specific populations of neurons affected by these diseases. Through its work, Rinat Neuroscience seeks to improve patient outcomes in the field of neurology.

Sosei Group Corporation is an international biopharmaceutical company based in Japan, focused on the discovery and development of innovative therapies for various medical conditions, including Alzheimer's disease, schizophrenia, cancer, migraine, addiction, and metabolic disorders. The company employs advanced technologies such as GPCR structure-based drug design, peptide platforms, and nanotechnology to create a promising product pipeline with first or best-in-class potential. Sosei Group has successfully partnered in the development and commercialization of three medicines, including two for chronic obstructive pulmonary disease (COPD) and an emergency contraceptive, which provide significant and stable revenue streams to support its ongoing growth and innovation efforts.

A storage company focused on holographic data storage technology.

Calmetrics, Inc. is a technology company based in Alameda, California, that specializes in developing enabling technology for optical media storage and manufacturing reference standards for XRF coating thickness and composition analysis systems. Founded in 1994, Calmetrics employs its patented ML™ technology to enhance the capacity and performance of optical media storage across various markets, including enterprise, desktop, and consumer electronics. This technology allows for significant improvements at minimal cost while maintaining compatibility with existing systems. In addition, Calmetrics produces a diverse array of reference standards for calibration purposes, which encompass thin and thick films, alloy films, and bulk standards made from precious metals, catering to a wide spectrum of industrial and scientific applications.

Beenos is a Tokyo-based venture capital firm that specializes in early-stage investments, focusing on consumer-facing companies across various sectors, including information technology, online marketplaces, and mobile applications. Founded in 1999, Beenos initially operated as NetPrice.com, offering eCommerce services before pivoting to incubation and venture capital in 2014. The firm’s investment strategy extends to diverse markets, primarily targeting the United States, India, Indonesia, Japan, and Turkey. Beenos aims to support startups through its team of experienced professionals who provide expertise in engineering, design, data science, and business management, assisting entrepreneurs in launching and scaling their businesses in the dynamic IT landscape.

Magically, Inc., the Worldwide leader in Communication & Collaboration technologies focuses on Personal communication and collaboration components. Magically's technology solutions, designed for the mobile work force and virtual communities, are universally accessible through multiple platforms, in any language and from any Internet enabled device. MagicalDesk, the flagship product, is an award-winning suite of information management tools for the corporate / SME user. Magically's newest product, Magical WorkSpace, is an enterprise application focused on workflow and team collaboration. Based in Redwood City, California, Magically is a privately owned and operated company with offices in Hong Kong, UK and Tokyo.

Silicon Wave, based in San Diego, specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating chips for wireless and broadband communications, positioning itself as a pioneer in Bluetooth wireless technology. Its expertise lies in producing RF systems-on-chip that are integral to various applications within the wireless communication sector.